Lutein + zeaxanthin
Macular carotenoids tested in the AREDS2 RCT in people with intermediate or advanced AMD, where the primary analysis was null and later analyses showed a small benefit.
- Evidence
- Preliminary evidenceGRADE certainty: Low
- Typical dose
- AREDS2 dose: 10 mg lutein + 2 mg zeaxanthin per day
- Time to effect
- Macular pigment optical density changes over 3–6 months
- Safety
- Has documented cautions
Evidence ratings summarise published research on Lutein + zeaxanthin in general. They are not a health claim for any product and not advice for any individual. Talk to your doctor before starting anything new, especially if you take medication.
Ask about Lutein + zeaxanthin
Interactions
Taking any medication?
Check Lutein + zeaxanthin against it.
Why
Lutein and zeaxanthin are dietary carotenoids that concentrate in the macula of the retina, the macular pigment. The AREDS2 trial (Chew JAMA 2013, n=4,203) tested lutein 10 mg + zeaxanthin 2 mg daily added to the AREDS formulation in adults at risk of AMD progression; in the primary analysis this did not significantly reduce progression to advanced AMD. Exploratory analyses and a 10-year follow-up suggested a small reduction in late AMD (HR about 0.90). Lutein/zeaxanthin replaced beta-carotene in the AREDS2 formulation (lung cancer signal with beta-carotene in former smokers). NICE treats the evidence for these supplements as an unresolved gap.
How it works
Filter blue light at the macula and quench reactive oxygen species generated by photoreceptor metabolism. Cross the blood-retinal barrier and concentrate in macular pigment, increasing its optical density.
Expected onset · Macular pigment optical density changes over 3–6 months; AMD progression endpoints over years
How to take
Dosage
AREDS2 dose: 10 mg lutein + 2 mg zeaxanthin per day. Higher doses (up to 20 mg lutein) have been used in shorter trials without added benefit.
Timing
Once daily with a meal containing fat for absorption
On the label
10 mg lutein + 2 mg zeaxanthin (AREDS2 dose). Usually derived from marigold (Tagetes erecta) extract.
Studied in
Adults with intermediate or advanced AMD in one eye, the group studied in AREDS2, under ophthalmology guidance.
Safety
Evidence
AREDS2 Research Group 2013 JAMA RCT (n=4,203): adding lutein plus zeaxanthin did not significantly reduce progression to advanced AMD in the primary analysis (HR 0.90, 98.7% CI 0.76-1.07). Exploratory analyses and a 10-year follow-up found a small reduction in late AMD (HR about 0.90-0.91). NICE guideline NG82 (2018) treats these supplements as an evidence gap.
GRADE certainty: Low — rated by Healicus using the GRADE method
- Age-Related Eye Disease Study 2 (AREDS2) Research Group, JAMA 2013, lutein + zeaxanthin and omega-3 fatty acids for AMD progression (RCT, n=4,203)
- Age-Related Eye Disease Study 2 (AREDS2) Research Group et al., Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3, JAMA Ophthalmol 2014
- Chew EY et al., Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28, JAMA Ophthalmol 2022
- Evans JR, Lawrenson JG, Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration, Cochrane Database Syst Rev 2023
- NICE guideline (2018): Age-related macular degeneration (NG82)
Questions people ask
Does Lutein + zeaxanthin work?
AREDS2 Research Group 2013 JAMA RCT (n=4,203): adding lutein plus zeaxanthin did not significantly reduce progression to advanced AMD in the primary analysis (HR 0.90, 98.7% CI 0.76-1.07). Exploratory analyses and a 10-year follow-up found a small reduction in late AMD (HR about 0.90-0.91). NICE guideline NG82 (2018) treats these supplements as an evidence gap. Certainty of the evidence: Low, rated by Healicus using the GRADE method.
How is Lutein + zeaxanthin taken?
AREDS2 dose: 10 mg lutein + 2 mg zeaxanthin per day. Higher doses (up to 20 mg lutein) have been used in shorter trials without added benefit. Timing: Once daily with a meal containing fat for absorption. Ranges are those reported in the cited sources, not individual advice; talk to your doctor or pharmacist before starting, especially if you take medication.
Are there interactions or cautions?
Few side effects were reported at AREDS2 doses. Mild yellowing of skin at very high doses (carotenodermia), reversible. Replaced beta-carotene in the AREDS2 formulation because beta-carotene raised lung-cancer risk in current/former smokers; lutein/zeaxanthin showed no significant lung-cancer increase in AREDS2 follow-up. Pregnancy and breastfeeding: dietary intake is not a documented concern; supplement-dose data limited. Documented drug and supplement interactions can be looked up in the free interaction reference.
What is the evidence based on?
Sources: Age-Related Eye Disease Study 2 (AREDS2) Research Group, JAMA 2013, lutein + zeaxanthin and omega-3 fatty acids for AMD progression (RCT, n=4,203); Age-Related Eye Disease Study 2 (AREDS2) Research Group et al., Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3, JAMA Ophthalmol 2014; Chew EY et al., Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28, JAMA Ophthalmol 2022; Evans JR, Lawrenson JG, Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration, Cochrane Database Syst Rev 2023; NICE guideline (2018): Age-related macular degeneration (NG82).
One evidence finding a day, like this one: follow Healicus on Threads or Bluesky.